Compare Cadila Healthcare with ALEMBIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ALEMBIC - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ALEMBIC 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ALEMBIC CADILA HEALTHCARE/
ALEMBIC
 
P/E (TTM) x 28.7 56.6 50.8% View Chart
P/BV x 4.6 4.9 94.9% View Chart
Dividend Yield % 0.7 0.2 356.6%  

Financials

 CADILA HEALTHCARE   ALEMBIC
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
ALEMBIC
Mar-18
CADILA HEALTHCARE/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs35272 489.3%   
Low Rs20734 609.1%   
Sales per share (Unadj.) Rs139.24.7 2,961.9%  
Earnings per share (Unadj.) Rs11.86.1 192.7%  
Cash flow per share (Unadj.) Rs18.66.2 297.3%  
Dividends per share (Unadj.) Rs3.500.20 1,750.0%  
Dividend yield (eoy) %1.30.4 331.6%  
Book value per share (Unadj.) Rs101.440.7 249.3%  
Shares outstanding (eoy) m1,023.74267.03 383.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.011.3 17.8%   
Avg P/E ratio x23.78.7 273.8%  
P/CF ratio (eoy) x15.08.5 177.5%  
Price / Book Value ratio x2.81.3 211.7%  
Dividend payout %29.83.3 907.9%   
Avg Mkt Cap Rs m286,03314,139 2,023.0%   
No. of employees `00013.4NA-   
Total wages/salary Rs m24,145207 11,641.8%   
Avg. sales/employee Rs Th10,632.7NM-  
Avg. wages/employee Rs Th1,801.2NM-  
Avg. net profit/employee Rs Th898.5NM-  
INCOME DATA
Net Sales Rs m142,5311,255 11,355.2%  
Other income Rs m1,139370 307.7%   
Total revenues Rs m143,6701,625 8,839.1%   
Gross profit Rs m24,198111 21,780.4%  
Depreciation Rs m6,96538 18,425.9%   
Interest Rs m3,4182 201,058.8%   
Profit before tax Rs m14,954442 3,384.8%   
Minority Interest Rs m2880-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,19824 13,352.8%   
Profit after tax Rs m12,0441,630 739.0%  
Gross profit margin %17.08.9 191.8%  
Effective tax rate %21.45.4 394.5%   
Net profit margin %8.5129.8 6.5%  
BALANCE SHEET DATA
Current assets Rs m87,1541,867 4,667.9%   
Current liabilities Rs m82,694591 13,987.5%   
Net working cap to sales %3.1101.6 3.1%  
Current ratio x1.13.2 33.4%  
Inventory Days Days7194 75.8%  
Debtors Days Days9474 127.6%  
Net fixed assets Rs m133,2361,791 7,439.6%   
Share capital Rs m1,024534 191.7%   
"Free" reserves Rs m102,73310,324 995.1%   
Net worth Rs m103,75710,858 955.6%   
Long term debt Rs m32,14641 78,024.3%   
Total assets Rs m236,86611,591 2,043.6%  
Interest coverage x5.4260.9 2.1%   
Debt to equity ratio x0.30 8,164.9%  
Sales to assets ratio x0.60.1 555.6%   
Return on assets %6.514.1 46.4%  
Return on equity %11.615.0 77.3%  
Return on capital %13.715.2 90.4%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m52,75219 271,917.5%   
Fx outflow Rs m14,504264 5,497.7%   
Net fx Rs m38,248-244 -15,648.5%   
CASH FLOW
From Operations Rs m25,054236 10,625.1%  
From Investments Rs m-10,123-224 4,519.2%  
From Financial Activity Rs m-10,942-27 41,135.3%  
Net Cashflow Rs m3,989-15 -26,952.7%  

Share Holding

Indian Promoters % 74.8 64.0 116.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 0.2 4,150.0%  
FIIs % 5.9 9.7 60.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 26.1 42.1%  
Shareholders   44,069 54,701 80.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  TORRENT PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Dow Futures Up by 90 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 34 points, up 0.1% at 48,844 levels.

Related Views on News

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 25, 2021 03:36 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS